Log In
Print this Print this

HDC docetaxel (STA-9183)

  Manage Alerts
Collapse Summary General Information
Company Synta Pharmaceuticals Corp.
DescriptionHsp90-inhibitor drug conjugate (HDC) composed of an inhibitor of heat shock protein 90 (Hsp90) joined to docetaxel via a cleavable chemical linker
Molecular Target Heat shock protein 90 (Hsp90)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today